日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial

慢性乙型肝炎伴轻度转氨酶升高患者的抗病毒治疗:TORCH-B试验的延续研究

Hsu, Yao-Chun; Chen, Chi-Yi; Tseng, Cheng-Hao; Chen, Chieh-Chang; Lee, Teng-Yu; Bair, Ming-Jong; Chen, Jyh-Jou; Huang, Yen-Tsung; Chang, I-Wei; Chang, Chi-Yang; Wu, Chun-Ying; Wu, Ming-Shiang; Mo, Lein-Ray; Lin, Jaw-Town

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study

直接抗病毒疗法治疗丙型肝炎病毒相关肝细胞癌患者:一项全国性队列研究

Lee, Shou-Wu; Yang, Sheng-Shun; Tsai, Pei-Chien; Huang, Chung-Feng; Chen, Chi-Yi; Hung, Chao-Hung; Chen, Chien-Hung; Tai, Chi-Ming; Cheng, Pin-Nan; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Mo, Lein-Ray; Lo, Ching-Chu; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Pei-Lun; Bair, Ming-Jong; Chang, Te-Sheng; Lin, Chun-Yen; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Yang, Tzeng-Hue; Peng, Cheng-Yuan; Yang, Chi-Chieh; Chong, Lee-Won; Huang, Chien-Wei; Lin, Chih-Wen; Chu, Cheng-Hsin; Tsai, Ming-Chang; Kao, Jia-Horng; Liu, Chun-Jen; Chuang, Wan-Long; Lee, Teng-Yu; Yu, Ming-Lung

Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

台湾全国丙型肝炎病毒登记研究揭示了在合并早期慢性肾病或终末期肾病前期慢性丙型肝炎患者中,普遍采用8周格卡瑞韦/哌仑他韦治疗的真实世界疗效和安全性:

Wang, Szu-Jen; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Kuo, Hsing-Tao; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Wang, Shu-Chi; Yu, Ming-Lung

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan

索非布韦/维帕他韦治疗对2型糖尿病合并慢性丙型肝炎患者肝外表现的影响:来自台湾全国丙型肝炎病毒登记研究的启示

Wang, Szu-Jen; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Bair, Ming-Jong; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Lin, Chih-Lang; Yang, Chi-Chieh; Kuo, Hsing-Tao; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Wang, Shu-Chi; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Huang, Chung-Feng; Yu, Ming-Lung

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

人工智能预测丙型肝炎病毒患者直接抗病毒药物治疗失败:一项全国性丙型肝炎病毒登记计划

Lu, Ming-Ying; Huang, Chung-Feng; Hung, Chao-Hung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; Liu, Chun-Jen; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan; Tsai, Chun-Wei-; Chen, Chi-Yi; Yu, Ming-Lung

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan

基于台湾全国数据的简化丙型肝炎病毒治疗算法(无需专科医生诊治)

Yu, Ming-Lung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Huang, Chung-Feng; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Hung, Chao-Hung; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; Liu, Chun-Jen; Dai, Chia-Yen; Chen, Chi-Yi; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

台湾全国丙型肝炎登记研究:格卡瑞韦/哌仑他韦通用方案8周治疗初治丙型肝炎患者的真实世界疗效和安全性

Yang, Chun-Chi; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Kuo, Hsing-Tao; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Yu, Ming-Lung

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry

一项基于台湾全国丙型肝炎登记研究的真实世界研究显示,格卡瑞韦/哌仑他韦联合治疗8周对初治代偿期肝硬化丙型肝炎患者的疗效和安全性。

Chang, Te-Sheng; Huang, Chung-Feng; Kuo, Hsing-Tao; Lo, Ching-Chu; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Chen, Chi-Yi; Tseng, Kuo-Chih; Hung, Chao-Hung; Yu, Ming-Lung

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

索非布韦/维帕他韦治疗丙型肝炎病毒感染:来自台湾全国注册研究的真实世界疗效和安全性

Cheng, Pin-Nan; Mo, Lein-Ray; Chen, Chun-Ting; Chen, Chi-Yi; Huang, Chung-Feng; Kuo, Hsing-Tao; Lo, Ching-Chu; Tseng, Kuo-Chih; Huang, Yi-Hsiang; Tai, Chi-Ming; Peng, Cheng-Yuan; Bair, Ming-Jong; Chen, Chien-Hung; Yeh, Ming-Lun; Lin, Chih-Lang; Lin, Chun-Yen; Lee, Pei-Lun; Chong, Lee-Won; Hung, Chao-Hung; Chang, Te Sheng; Huang, Jee-Fu; Yang, Chi-Chieh; Hu, Jui-Ting; Lin, Chih-Wen; Wang, Chia-Chi; Su, Wei-Wen; Hsieh, Tsai-Yuan; Lin, Chih-Lin; Tsai, Wei-Lun; Lee, Tzong-Hsi; Chen, Guei-Ying; Wang, Szu-Jen; Chang, Chun-Chao; Yang, Sheng-Shun; Wu, Wen-Chih; Huang, Chia-Sheng; Chou, Kwok-Hsiung; Kao, Chien-Neng; Tsai, Pei-Chien; Liu, Chen-Hua; Lee, Mei-Hsuan; Cheng, Chien-Yu; Tsai, Ming-Chang; Liu, Chun-Jen; Dai, Chia-Yen; Lin, Han-Chieh; Kao, Jia-Horng; Chuang, Wan-Long; Yu, Ming-Lung

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals

接受直接抗病毒药物治疗的血小板减少性慢性丙型肝炎患者血小板计数显著改善的相关因素

Chen, Yen-Chun; Chang, Te-Sheng; Chen, Chien-Hung; Cheng, Pin-Nan; Lo, Ching-Chu; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Chung-Feng; Kuo, Hsing-Tao; Huang, Yi-Hsiang; Tai, Chi-Ming; Peng, Cheng-Yuan; Bair, Ming-Jong; Yeh, Ming-Lun; Lin, Chih-Lang; Lin, Chun-Yen; Lee, Pei-Lun; Chong, Lee-Won; Hung, Chao-Hung; Huang, Jee-Fu; Yang, Chi-Chieh; Hu, Jui-Ting; Lin, Chih-Wen; Wang, Chia-Chi; Su, Wei-Wen; Hsieh, Tsai-Yuan; Lin, Chih-Lin; Tsai, Wei-Lun; Lee, Tzong-Hsi; Chen, Guei-Ying; Wang, Szu-Jen; Chang, Chun-Chao; Yang, Sheng-Shun; Wu, Wen-Chih; Huang, Chia-Sheng; Hsiung, Chou-Kwok; Kao, Chien-Neng; Tsai, Pei-Chien; Liu, Chen-Hua; Lee, Mei-Hsuan; Dai, Chia-Yen; Kao, Jia-Horng; Chuang, Wan-Long; Lin, Han-Chieh; Chen, Chi-Yi; Tseng, Kuo-Chih; Yu, Ming-Lung; On Behalf Of Tacr Investigators